PULM Pulmatrix


Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 17, 2021, Pulmatrix, Inc. (the “Company”) held its 2021 annual meeting of stockholders (the “Annual Meeting”). A total of 31,388,300 shares of the Company’s common stock were present in person or represented by proxy at the Annual Meeting. Holders of the Company’s common stock were entitled to one vote per share. The matters submitted for a vote and the related results are set forth below.

(1)Election of two directors to serve as Class I directors on our Board of Directors to serve until our 2024 Annual Meeting of Stockholders or until successors have been duly elected and qualified:

DirectorForAgainstWithheld /AbstainedBroker Non-Votes
Todd Bazemore17,811,3220933,56312,643,414
Christopher Cabell, M.D.16,146,00402,598,88112,643,414

(2)Ratification of the appointment of Marcum LLP as our independent registered public accounting firm for the 2021 fiscal year:

ForAgainstWithheld /AbstainedBroker Non-Votes

For more information about the foregoing proposals, see the Company’s definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on April 29, 2021, the relevant portions of which are incorporated herein by reference.

The results reported above are final voting results. No other matters were considered or voted upon at the meeting.